Records containing: Migraine
This is the wording recorded or indexed by the source. An agency index term is not necessarily an authorised indication. Co-listed drug names are not linked to this term as a treatment relationship.
Follow recorded terms in Drug Alerts for Android. Free includes unlimited local condition follows and an on-open recent-record watchlist. Plus adds no ads and personal organization tools.
All
FDA submission records
EMA medicine records
ClinicalTrials.gov record updates
ClinicalTrials.gov records with results posted
-
CLINICAL_TRIALS study record update · 2022-11-02Effectiveness and Tolerability of Repetitive Transcranial Magnetic Stimulation For Preventive Treatment Of Episodic Migraine: A Single Centre, Randomised, Double-Blind, Sham-Controlled Phase 2 Trial
-
CLINICAL_TRIALS study record update · 2022-10-31Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study to Evaluate the Efficacy and Safety of Eptinezumab for the Preventive Treatment of Migraine in Patients With a Dual Diagnosis of Migraine and Medication Overuse Headache
-
CLINICAL_TRIALS study record update · 2022-10-24Hypersensitivity to CGRP as a Predictive Biomarker of Migraine Prevention With Erenumab
-
CLINICAL_TRIALS study record update · 2022-10-20Non-interventional Study of the Austrian Headache Society: Monoclonal CGRP Antibodies for Migraine Prevention a Nationwide Real Life Study
-
CLINICAL_TRIALS study record update · 2022-10-13Phase II/III: Double-Blind, Randomized, Placebo-Controlled, Dose-Ranging Trial of BHV-3500 for the Acute Treatment of Migraine
- Organize your saved records without ads with Plus.
-
CLINICAL_TRIALS study record update · 2022-10-05A Multicenter, Open Label Study Assessing the Efficacy of Erenumab on Functional Impact of Migraine
-
CLINICAL_TRIALS study record update · 2022-10-04A Prospective, Randomized, Vehicle-Controlled, Double-Blind, Phase 2 Study to Assess the Safety, Tolerability, and Efficacy of B244 Delivered as an Intranasal Spray for Preventive Treatment in Subjects With Episodic Migraine
-
CLINICAL_TRIALS study record update · 2022-07-22Interventional, Randomized, Double-blind, Parallel-group, Placebo-controlled Study With an Extension Period to Evaluate the Efficacy and Safety of Eptinezumab for the Prevention of Migraine in Patients With Unsuccessful Prior Preventive Treatments
-
CLINICAL_TRIALS study record update · 2022-07-21Randomized, Triple-blind, Placebo Controlled Study to Evaluate the Efficacy of Individualized Homeopathic Remedies With High Grade of Pathological Similarity vs Conventional Standardized Pharmacological Treatment in Patients With Migraine.
-
CLINICAL_TRIALS study record update · 2022-07-21Feasibility of Using a Mobile Device Controlled Micro-pressure Pulse Insufflator for Acute Migraine Relief
-
CLINICAL_TRIALS study record update · 2022-07-20Effect of Erenumab-aooe on Disability and Work Productivity in Employed Subjects With Episodic Migraine Who Have Previously Failed 1 or More Migraine Preventive Treatments.
-
CLINICAL_TRIALS study record update · 2022-07-13The Effect of Topiramate on Etonogestrel Concentrations in Contraceptive Implant Users
-
CLINICAL_TRIALS study record update · 2022-07-12Investigation and Modulation of the Mu-Opioid Mechanisms in Migraine (in Vivo)
-
CLINICAL_TRIALS study record update · 2022-07-11RELAXaHEAD for Headache Patients (Phase I)
-
CLINICAL_TRIALS study record update · 2022-07-01Study of Early MIDAS Reduction at 3 Months as Predictor of Long-term Erenumab Treatment in Chronic Migraine: a Real-life, Open-label, Trial
-
CLINICAL_TRIALS study record update · 2022-07-01Real-world Impact of Erenumab on Sick-leaves, Health Care Resource Use and Comorbidities Based on Occupational Health Care Registry in Finland: an Observational Retrospective Mirror-image Study (REFI)
-
CLINICAL_TRIALS study record update · 2022-06-23Omega-3 Fatty Acid in the Prevention of Migraine: From the Randomized Clinical Trial to Molecular Biology Approaches
-
CLINICAL_TRIALS study record update · 2022-06-23A Multi-center, Randomized, Double-blind, Placebo-controlled Parallel Pilot Study to Evaluate Safety and Efficacy of Oral Idebenone for Preventive Treatment of Migraine in Adult Migraine Patients
-
CLINICAL_TRIALS study record update · 2022-06-16A Phase 1b, Open-label, Fixed-sequence, Safety, Tolerability and Drug-drug Interaction Study Between Atogepant and Ubrogepant in Participants With a History of Migraine
-
CLINICAL_TRIALS study record update · 2022-06-03A Multinational, Multi-centre, Randomised, Double-blind, Placebo-controlled, 3-way Crossover Study in Migraine Patients, Treated With Two Doses of BGC20-1531 and Placebo
-
CLINICAL_TRIALS study record update · 2022-05-19The Effects of Triggering Points Dry Needling on Sternocleidomastoid Muscle for Pain and Disability in Migraine
-
CLINICAL_TRIALS study record update · 2022-05-19Botox Vs Spinal Cord Stimulation in the Treatment of Refractory Migraine
-
CLINICAL_TRIALS study record update · 2022-05-13Effects of Transcutaneous Occipital Nerve Stimulation and Instrument-Assisted Soft Tissue Mobilization in Chronic Migraine
-
CLINICAL_TRIALS study record update · 2022-05-04Migraine in Poland - a Web-based Cross-sectional Survey
-
CLINICAL_TRIALS study record update · 2022-04-20A Randomized, Open-Label, 5-Period Crossover Study to Evaluate the PK, Bioavailability, Safety, and Tolerability of Single Doses of STS101, DHE IM Injection and DHE Nasal Spray in Healthy Adult Subjects